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Despite its toxicity, H2O2 is produced as a signaling
molecule that oxidizes critical cysteine residues of
effectors such as protein tyrosine phosphatases in
response to activation of cell surface receptors. It
has remained unclear, however, how H2O2 concen-
trations above the threshold required to modify
effectors are achieved in the presence of the abun-
dant detoxification enzymes peroxiredoxin (Prx) I
and II. We now show that PrxI associated with
membranes is transiently phosphorylated on tyro-
sine-194 and thereby inactivated both in cells stimu-
lated via growth factor or immune receptors in vitro
and in those at the margin of healing cutaneous
wounds in mice. The localized inactivation of PrxI
allows for the transient accumulation of H2O2 around
membranes, where signaling components are con-
centrated, while preventing the toxic accumulation
of H2O2 elsewhere. In contrast, PrxII was inactivated
not by phosphorylation but rather by hyperoxidation
of its catalytic cysteine during sustained oxidative
stress.
INTRODUCTION
Hydrogen peroxide (H2O2) is generated in all aerobic organisms
as a byproduct of normal cellular processes. Given that H2O2 is
toxic to cells, however, such organisms are equipped with
detoxifying enzymes such as catalase, glutathione peroxidases
(GPxs), and peroxiredoxins (Prxs).
Many mammalian cell types also produce H2O2 in response to
a variety of extracellular stimuli, with the H2O2 so produced
serving as a signaling molecule that regulates various biological
processes. Stimulation of cells with various agonists thus
induces H2O2 production, and blockage of H2O2 accumulation
results in inhibition of signaling by such stimulants (D’Autre´aux
and Toledano, 2007; Oakley et al., 2009; Rhee, 2006; Xu et al.,
2002). For example, in cells stimulated with growth factors
such as platelet-derived growth factor (PDGF) or epidermal
growth factor (EGF), production of H2O2 is required for propaga-tion of growth factor signaling (Bae et al., 1997; Sundaresan
et al., 1995). Among the best characterized H2O2 effectors are
protein tyrosine phosphatases (PTPs): H2O2 specifically oxidizes
the catalytic cysteine residue of these enzymes and thereby
inhibits their activity (Chiarugi and Cirri, 2003; Rhee et al.,
2005; Tonks, 2005). Indeed, the activation of protein tyrosine
kinases (PTKs) is not sufficient to increase the steady-state level
of protein tyrosine phosphorylation in cells; the concurrent inhi-
bition of PTPs by H2O2 is also required. Many other H2O2 effector
molecules also contain an H2O2-sensitive cysteine residue.
Evidence indicates that NADPH oxidase (Nox) is largely
responsible for receptor-dependent H2O2 production (Clempus
and Griendling, 2006; Lambeth, 2004; Oakley et al., 2009). Seven
distinct catalytic subunits of Nox (Nox1 to Nox5, Duox1, and
Duox2) have been identified (Lambeth, 2004). These catalytic
subunits are transmembrane proteins and form multisubunit
complexes with other membrane as well as cytosolic proteins.
Nox generates superoxide by transferring one electron from
NADPH to O2. Superoxide then undergoes dismutation to
H2O2. Activated Nox complexes appear to assemble within
discrete subcellular compartments, including lipid rafts and
endosomes, thereby making it possible to produce toxic H2O2
molecules within a restricted region of the cell (Li et al., 2006;
Oakley et al., 2009; Ushio-Fukai, 2006). For H2O2 to serve as
a signaling molecule, its concentration must increase rapidly
above a certain threshold (10 to 100 mM) and remain elevated
long enough for it to oxidize effector molecules (Stone and
Yang, 2006). However, in most cells, H2O2-eliminating enzymes
are present in large concentrations in the cytosol in order to
ensure that the toxic molecule remains at low intracellular levels
(<0.1 mM) (Stone and Yang, 2006).
PrxI to PrxIV belong to the 2-Cys Prx subfamily of Prx
enzymes, which exist as homodimers and reduce H2O2 with
the use of reducing equivalents provided by thioredoxin (Trx)
(Rhee et al., 2005). PrxI and PrxII are localized to the cytosol,
whereas PrxIII and PrxIV are restricted to mitochondria and the
endoplasmic reticulum, respectively. PrxI and PrxII are also
abundant, constituting a total of 0.2% to 1% of soluble protein
in cultured mammalian cells (Chae et al., 1999). Catalase is
exclusively localized in peroxisomes. GPx1 is present predomi-
nantly in the cytosol, but its concentration is smaller than that
of PrxI or PrxII in most tissues. Prx enzymes are efficient in elim-
inating low concentrations of H2O2 because of their low KmCell 140, 517–528, February 19, 2010 ª2010 Elsevier Inc. 517
Figure 1. Phosphorylation of PrxI and PrxII
In Vitro and Its Effect on the Catalytic
Activity of PrxI
(A) Purified recombinant human PrxI or II was
subjected to an in vitro kinase assay with Lck in
the presence of [g-32P]ATP. Proteins were sepa-
rated by SDS-PAGE and visualized by either auto-
radiography, immunoblot analysis with antibodies
to phosphorylated (p-) PrxI, or staining with
Ponceau S.
(B) Wild-type (WT) or mutant (Y194F) PrxI
expressed in and purified from TKB1 cells was
subjected to immunoblot analysis with antibodies
to phosphotyrosine (p-Tyr) or to phosphorylated or
total PrxI.
(C) Peroxidase activity of nonphosphorylated
(open circles) or Tyr194-phosphorylated (closed
squares) wild-type PrxI as well as of Y194D (open
triangles) or Y194F (closed triangles) mutants of
PrxI was monitored in the presence of 50 mM
H2O2 for 450 s as the decrease in A340 by coupling
of the reaction to NADPH oxidation (left panel). The
initial decrease in A340 between 20 and 100 s is
expanded in the right panel. NADPH oxidation in
the absence of any Prx enzyme (closed circles)
was also monitored.
(D) Ribbon diagram of PrxI showing the peroxi-
datic Cys (Cys52), which is located close to
Arg128 and Arg151 of the same subunit and under
the influence of the N-cap effect of helix a´2.
Phosphorylation of Tyr194 in the other subunit of
the homodimer introduces a phosphate group
(red, oxygen; violet, phosphorus) that is located
within a distance of 9 A˚ from the sulfur atom (yellow) of Cys52. Primed residue numbers correspond to the subunit whose catalytic Cys is not shown.
Additional information is provided in the Extended Experimental Procedures. See also Figure S1.values for this substrate (Chae et al., 1999). It has therefore re-
mained unclear how, in the presence of PrxI and II, H2O2 can
accumulate in the cytosol to a concentration sufficient for it to
modify target proteins.
The catalytic site of 2-Cys Prxs comprises the NH2-terminal
region of one subunit and the COOH-terminal region of the
other subunit in the homodimer (Rhee et al., 2005). The perox-
idatic Cys-SH (CP-SH) is located in the NH2-terminal region and
is selectively oxidized by H2O2 to CP-SOH, which then reacts
with the resolving Cys-SH (CR-SH) in the COOH-terminal region
of the other subunit to form an intermolecular disulfide. The
disulfide is reduced by Trx. During catalysis, the CP-SOH inter-
mediate occasionally undergoes further oxidation by H2O2 to
CP-SO2H before the relatively slow formation of a disulfide
with CR-SH can occur. This hyperoxidation, which results in
inactivation of peroxidase activity, is reversed by sulfiredoxin
(Biteau et al., 2003; Woo et al., 2003a). Given that bacterial
Prxs are resistant to hyperoxidation and that prokaryotes do
not express sulfiredoxin, reversible inactivation through hyper-
oxidation has been proposed to be a eukaryotic adaptation
that allows H2O2 to accumulate to substantial levels under
certain circumstances, thereby facilitating H2O2-dependent
signaling. This concept has been termed the ‘‘floodgate’’
hypothesis (Wood et al., 2003). However, no hyperoxidized
PrxI or II was observed in cells stimulated with PDGF (Choi
et al., 2005).518 Cell 140, 517–528, February 19, 2010 ª2010 Elsevier Inc.We have now found that PrxI is phosphorylated on Tyr194 and
is thereby inactivated in cells stimulated via receptors for growth
factors such as PDGF or EGF or via immune receptors such as
T cell (TCR) and B cell (BCR) receptors. This phosphorylation is
confined to PrxI molecules associated with cell membranes; it
was not observed with PrxI present in the cytosol. The spatially
confined inactivation of PrxI thus provides a means for gener-
ating favorable H2O2 gradients around a submembrane com-
partment, where signaling proteins are concentrated, while mini-
mizing the general accumulation of H2O2 to toxic levels and
disturbance of global redox potential.
RESULTS
Tyrosine Phosphorylation and Inactivation of PrxI
In Vitro
To determine whether Prxs are phosphorylated, we subjected
recombinant human PrxI and II to an in vitro kinase assay with
two nonreceptor PTKs, Lck and Abl, in the presence of
[g-32P]ATP. Both PTKs phosphorylated PrxI and PrxII, with the
extent of phosphorylation for the former being markedly greater
than that for the latter (Figure 1A, Figure S1A available online).
Tyrosine-194 of PrxI was one of 600 phosphorylation sites
revealed by a large-scale proteomic analysis in a cancer cell
line treated with pervanadate (Rush et al., 2005). We therefore
generated antibodies to Tyr194-phosphorylated PrxI by injection
with a phosphopeptide (KSKEpYFSKQK) corresponding to resi-
dues 190 to 199 of PrxI. The sequence SKEYFSK is conserved
between PrxI and II. The extents of PrxI and PrxII phosphoryla-
tion detected by immunoblot analysis with the phospho-specific
antibodies was similar to that revealed by measurement of 32P
radioactivity, indicative of similar reactivities of the antibodies
for the phosphorylated isozymes. To verify the phosphorylation
site of PrxI, we expressed wild-type PrxI or a Tyr194 to Phe
mutant (Y194F) in the PTK-expressing Escherichia coli strain
TKB1. Phosphorylation of the wild-type protein was detected,
whereas that of the Y194F mutant was not (Figure 1B), indicating
that Tyr194 is the only site of tyrosine phosphorylation.
We next investigated the effect of phosphorylation of PrxI on
its peroxidase activity by subjecting PrxI produced in TKB1
bacteria to affinity chromatography with an immobilized mono-
clonal antibody to phosphotyrosine (4G10) in order to separate
phosphorylated and nonphosphorylated proteins. The peroxi-
dase activity of phosphorylated and nonphosphorylated forms
of PrxI was then monitored in the presence of 50 mM H2O2 by
coupling the peroxidase reaction to NADPH oxidation. After
a lag time of 50 s, the reaction rate for phosphorylated PrxI
achieved a steady state that was approximately one-seventh
of that for nonphosphorylated PrxI (Figure 1C). No lag time was
observed for nonphosphorylated PrxI. The reaction rate for
nonphosphorylated PrxI decreased slightly with time because
CP-SH becomes hyperoxidized during catalysis (see below),
and the rate became zero when A340 reached 0.9 because of
exhaustion of H2O2 (Figure 1C). A similar lag time (20 s) and
reduced activity (approximately one-fourth of that for nonphos-
phorylated PrxI) were observed for phosphorylated PrxI when
the H2O2 concentration was increased to 500 mM (Figure S1B).
These results suggest that, at H2O2 concentrations in the low
micromolar range, the lag time for phosphorylated PrxI would
be substantially greater than 50 s and the steady-state reaction
rate would be much less than one-seventh of that for the non-
phosphorylated enzyme.
The catalytic CP-SH of PrxI is highly reactive with H2O2,
because it is surrounded by Arg128 and Arg151 that stabilize the
thiolate anion (CP-S
), which is more readily oxidized by H2O2
than is its protonated thiol counterpart. Structural modeling pre-
dicted that the phosphate moiety of phospho-Tyr194 of one
subunit of the PrxI homodimer is positioned within 9 A˚ of the
sulfur atom of CP-SH (Cys
52) of the other subunit (Figure 1D).
The negatively charged phosphate group might thus be
expected to impair the deprotonation of Cp-SH and thereby to
decrease its reactivity with H2O2. However, after CP-SH has
entered the catalytic cycle, reduction by Trx may return the CP
residue to a state that is not affected to the same extent by the
phosphate moiety and that is slightly more reactive with H2O2,
resulting in a catalytic activity for the phosphorylated enzyme
that is reduced but measurable. In support of this notion,
a PrxI mutant in which Tyr194 is replaced by Asp (Y194D), which
therefore contains a negatively charged carboxyl group at posi-
tion 194, exhibited an activity time course similar to that for phos-
phorylated PrxI, whereas neutral replacement of the same
residue by Phe did not substantially affect enzyme activity
(Figure 1C). Comparison of the structures of PrxI and PrxII might
also suggest an explanation for the observed slower phosphor-ylation of PrxII. His197 of PrxII appears to form a hydrogen bond
with Asp181, with this interaction possibly hindering access of
a PTK to Tyr193 (the residue corresponding to Tyr194 of PrxI) (Fig-
ure S1C). No analogous interaction is apparent in PrxI, in which
Gln is present at the position corresponding to His197 of PrxII.
Tyrosine Phosphorylation of PrxI in Cells Stimulated
with Growth Factors
With the antibodies specific for Tyr194-phosphorylated PrxI,
we next examined whether PrxI or PrxII is phosphorylated in
cells. PrxI and PrxII, which differ by one amino acid residue
in size, cannot be separated by SDS-PAGE. Immunoblot anal-
ysis revealed that stimulation of rat smooth muscle cells with
PDGF resulted in the transient phosphorylation of PrxI or II
(Figure 2A). Similar time-dependent phosphorylation of PrxI
or II was observed in NIH 3T3 cells stimulated with PDGF
(Figure S2A), HER (NIH 3T3 cells that stably express EGF
receptor) stimulated with PDGF or EGF (Figure 3, Figure S2B),
A431 cells stimulated with EGF (see Figure 4), Ramos B cells
stimulated with antibodies to IgM (see Figure 4), and Jurkat
T cells stimulated with antibodies to CD3 (see Figure 4). Stimula-
tion of mouse embryonic fibroblasts (MEFs) derived from wild-
type or PrxI knockout mice with PDGF yielded a phosphorylated
Prx band with the former cells but not with the latter (Figure 2B),
suggesting that PrxI is the primary target for growth factor-
induced phosphorylation.
Nox1 is the major catalytic subunit of Nox in keratinocytes
(Valencia and Kochevar, 2008). We compared PrxI phosphoryla-
tion in primary keratinocytes prepared from mice deficient in
Nox1 and their wild-type littermates. The extent of PrxI phos-
phorylation measured 2 min after the onset of stimulation with
EGF and PDGF was reduced by 60% in the Nox1-deficient
cells compared with that in the wild-type cells (Figure 2C), sug-
gesting that H2O2 generated by Nox1 augments the growth
factor-induced inactivation of PrxI, which in turn promotes
further accumulation of H2O2. This difference was reduced to
35% and 25%, respectively, at 5 and 10 min after exposure
to PDGF and EGF.
Two-dimensional (2D) PAGE separates not only PrxI and PrxII
but also their phosphorylated and nonphosphorylated forms.
2D-PAGE and subsequent immunoblot analysis with antibodies
to PrxI or to PrxII revealed that the intensity of spots correspond-
ing to the phosphorylated forms of PrxI or PrxII was too low to be
measured in PDGF-stimulated NIH 3T3 cells (data not shown).
However, stimulation of the cells with PDGF in the presence of
pervanadate resulted in a measurable increase in the amount
of phosphorylated PrxI, which accounted for 5% of total PrxI
(Figure S2C); phosphorylated PrxII was still not detected. On
the basis of comparison with the one-dimensional immunoblot
intensities obtained for cells stimulated with PDGF in the pres-
ence of pervanadate, the extent of PrxI phosphorylation in NIH
3T3 cells stimulated with PDGF alone was estimated to be
0.2% to 0.4% of total PrxI (Figure S2D).
Hyperoxidation of CP-SH to CP-SO2H is another mechanism of
PrxI inactivation that has been suggested to serve a signaling
function (Rhee, 2006; Wood et al., 2003). We therefore next
examined the relation between hyperoxidation and phosphoryla-
tion of PrxI or II in cells stimulated with growth factors.Cell 140, 517–528, February 19, 2010 ª2010 Elsevier Inc. 519
Figure 2. Tyrosine Phosphorylation of PrxI
in Growth Factor-Stimulated Cells and the
Role of Nox
(A and B) Rat smooth muscle cells (A) or MEFs
from wild-type (WT) or PrxI knockout (KO) mice
(B) were deprived of serum and then stimulated
with PDGF (25 ng/ml) for the indicated times, after
which cell lysates (25 mg protein) were subjected to
immunoblot analysis with antibodies to phosphor-
ylated or total PrxI.
(C) Keratinocytes isolated from wild-type or Nox1
knockout mice were deprived of serum and then
stimulated with EGF (50 ng/ml) and PDGF (25 ng/
ml) in the presence of 5 mM sodium pervanadate
for the indicated times, after which cell lysates
were analyzed as in (A) and (B) (upper panel).
The relative extent of PrxI phosphorylation was
estimated from the immunoblot band intensities
(lower panel); data are presented as mean ± stan-
dard error of the mean (SEM) from five indepen-
dent measurements. *p < 0.01 versus correspond-
ing wild-type value.
(D) HepG2 cells stably expressing PDGFR and
Nox1 were transfected with expression vectors
for Noxo1 and Noxa1 (right) or with the corre-
sponding empty vectors (left), deprived of serum,
and then stimulated with PDGF (25 ng/ml) in the
presence of 2 mM sodium pervanadate for the indi-
cated times. Cell lysates (20 mg protein) were sub-
jected to immunoblot analysis with antibodies to
phosphorylated or total PrxI or to hyperoxidized
2-Cys Prxs (Prx-SO2). Lysates (5 mg protein) of
cells exposed to 1 mM H2O2 for 10 min were simi-
larly analyzed as a positive control for Prx hyper-
oxidation (right-most lanes).
See also Figure S2.Immunoblot analysis of PDGF-stimulated rat smooth muscle
cells or NIH 3T3 cells with antibodies specific for hyperoxidized
2-Cys Prxs did not detect hyperoxidized PrxI or II. We then
increased the extent of PDGF-induced H2O2 generation in
HepG2 cells by overexpressing the PDGF receptor (PDGFR),
Nox1, and two additional proteins (Noxo1 and Noxa1) that are
necessary for activation of Nox1. The enhanced signaling attrib-
utable to the increased H2O2 production in the transfected cells
was manifest by an increased level of PDGF-induced phosphor-
ylation of PrxI (Figure 2D) as well as of other proteins such as
PDGFR and PLC-g (data not shown). Such enhanced phosphor-
ylation was the result of increased inhibition of PTPs by the
increased amounts of H2O2. Even under these conditions, hyper-
oxidation of PrxI or II was not detected (Figure 2D), suggesting
that H2O2 produced in response to growth factor stimulation
does not induce hyperoxidation of PrxI or PrxII.
To examine whether PrxI inactivation by phosphorylation
participates in receptor signaling, we assessed the phosphoryla-
tion of PDGFR and PLC-g in PrxI-deficient MEFs reconstituted
with either wild-type or Y194F mutant PrxI (Figure S2E). PLC-g
is known to be phosphorylated by PDGFR after binding to auto-
phosphorylated PDGFR via its SH2 domain. The extent of phos-
phorylation of both proteins measured at 5, 10, and 15 min after
PDGF stimulation was reduced by 20% to 30% in the cells
expressing the phosphorylation-resistant mutant PrxI compared520 Cell 140, 517–528, February 19, 2010 ª2010 Elsevier Inc.with that in the wild-type-expressing cells, suggesting that inac-
tivation of PrxI through Tyr194 phosphorylation promotes PDGF-
dependent tyrosine phosphorylation of cellular proteins.
To identify the PTK responsible for PrxI phosphorylation, we
examined the effects of PTK inhibitors. PrxI associates with
Abl (Wen and Van Etten, 1997), which is activated in response
to PDGF or EGF stimulation (Plattner et al., 1999). STI571 (imati-
nib mesylate), a highly specific inhibitor of the kinase activities of
Abl and PDGFR (Carroll et al., 1997), blocked the induction of
PrxI phosphorylation by PDGF, but not that elicited by EGF, in
HER cells (Figure 3A), suggesting that Abl is not the kinase
responsible for PrxI phosphorylation. EGF-induced phosphory-
lation of PrxI in A431 cells was blocked by the EGF receptor
(EGFR)-specific inhibitor AG1478 (Figure 3B). Both PDGF-
induced (data not shown) and EGF-induced (Figure 3C) PrxI
phosphorylation were markedly inhibited by PP1, a specific
inhibitor of Src family PTKs. Ligation of PDGFR, EGFR, or BCR
triggers signaling pathways mediated by the Src family of nonre-
ceptor PTKs, which are expressed in most cell types. The BCR-
dependent phosphorylation of PrxI was also inhibited by PP1 in
Ramos cells (Figure 3D). To provide further evidence for the role
of Src kinases in PrxI phosphorylation, RNA interference was
employed to knockdown c-Src in NIH 3T3 cells. c-Src expres-
sion in NIH 3T3 cells transfected with Src small interfering RNA
(siRNA) was reduced by 50% compared to expression in cells
Figure 3. Effects of PTK Inhibitors on PrxI Phosphorylation
(A) Serum-deprived HER cells were incubated for 30 min in the absence (Con.) or presence of 5 mM STI571 and then for the indicated times in the additional
presence of PDGF (25 ng/ml) or EGF (50 ng/ml). Cell lysates (25 mg protein) were then subjected to immunoblot analysis with antibodies to phosphorylated or
total PrxI or to phosphotyrosine (p-Tyr).
(B and C) Serum-deprived A431 cells were incubated for 30 min in the absence (Con.) or presence of 1 mM AG1478 (B) or 10 mM PP1 (C) and then for the indicated
times in the additional presence of EGF (50 ng/ml). Cell lysates (25 mg protein) were then subjected to immunoblot analysis with antibodies to phosphorylated or
total forms of PrxI, EGFR, or Src.
(D) Serum-deprived Ramos cells were incubated for 30 min in the absence (Con.) or presence of 10 mM PP1 and then for 5 min in the additional absence or pres-
ence of antibodies to IgM (15 mg/ml), after which cell lysates (25 mg protein) were subjected to immunoblot analysis with antibodies to phosphorylated or total
forms of Src or PrxI.
See also Figure S3.transfected with control siRNA (Figure S3). The reduced Src
expression was associated with a 25%–50% decrease in
PDGF-induced PrxI phosphorylation (Figure S3), supporting
the notion that c-Src is at least partly responsible for PrxI phos-
phorylation in PDGF-stimulated cells.
Phosphorylation of PrxI Associated with Cell
Membranes
Nox1 and Nox2 are activated within a submembrane compart-
ment that are characterized by their resistance to nonionic deter-
gents, and both receptor PTKs and Src family kinases are consti-
tutively associated with such domains (Ushio-Fukai, 2006;
Oakley et al., 2009). We therefore examined whether the low
level of growth factor-induced PrxI phosphorylation (Fig-
ure S2D) might reflect restriction of the phosphorylation event
to confined area of membranes. Detergent-soluble and -resis-
tant fractions were isolated from A431 cells that had been stim-
ulated with EGF for 5 min and were subjected to immunoblot
analysis. The lipid raft-associated protein flotillin 2 (Flot2) (Riento
et al., 2009) and phosphorylated PrxI were detected only in the
detergent-resistant fraction (Figure 4A). In contrast, PrxI and
PrxII were present mostly in the soluble fraction but were also
associated with detergent-resistant fraction (Figure 4A), withthis association being independent of growth factor stimulation
(data not shown). GPx1, another H2O2-eliminating enzyme,
was detected in the soluble fraction but not in the insoluble
fraction (data not shown). Consistent with previous observations
(Li et al., 2008), Tyr416-phosphorylated and total forms of Src
were detected almost exclusively in the insoluble fraction. Simi-
larly, phosphorylated PrxI was detected only in the insoluble
fraction of NIH 3T3 cells stimulated with PDGF (Figure 4B). The
compartmentalized phosphorylation of PrxI was also observed
in Ramos and Jurkat cells stimulated via BCR and TCR, respec-
tively (Figures 4C and 4D). The TCR is constitutively localized to
a submembrane compartment (Miceli et al., 2001), whereas the
BCR is translocated to similar compartment in response to its
ligation (Cheng et al., 2001). Initial signaling initiated by the two
immune receptors is also mediated by members of the Src
kinase family.
We monitored the tyrosine phosphorylation of PrxI in A431
cells stimulated with EGF for 0, 1, 3, 5, or 20 min with the use
of confocal immunofluorescence microscopy (Figure S4A). The
maximal increase was observed at 5 min, after which the extent
of phosphorylation decreased. Phosphorylated PrxI in the
cells stimulated for 5 min was found to colocalize with Flot2
(Figure 4E).Cell 140, 517–528, February 19, 2010 ª2010 Elsevier Inc. 521
Figure 4. Phosphorylation of PrxI Associated with Confined Membrane Microdomains
(A–D) Serum-deprived A431 cells (A), NIH 3T3 cells (B), Ramos B cells (C), and Jurkat T cells (D) were stimulated for 5 min with EGF (50 ng/ml), PDGF (25 ng/ml),
antibodies to IgM (15 mg/ml), or antibodies to CD3 (10 mg /ml), respectively, after which detergent-soluble (S) and -resistant (R) fractions were prepared from cell
lysates and subjected to immunoblot analysis with antibodies to the indicated proteins. In (C) and (D), antibodies to phosphotyrosine were used to detect phos-
phorylated nonreceptor PTKs (p-Syk, p-Lyn, p-ZAP70, p-Lck, and p-Fyn), with the size of molecular markers (in kilodaltons) being indicated on the right.
(E) Serum-deprived A431 cells were incubated for 5 min in the absence or presence of EGF (50 ng/ml), fixed, and subjected to immunofluorescence staining with
antibodies to phosphorylated PrxI (green) and to Flot2 (red). Merged images with nuclei stained with 40,6-diamidino-2-phenylindole (blue) are also shown. The
regions indicated by the arrows are shown at higher magnification in the insets. The scale bar represents 20 mm.
See also Figure S4.To examine whether phosphorylated PrxI colocalizes with
activated Nox1, GFP-tagged Noxo1 was transfected into A431
cells. Activation of Nox1 requires translocation of two cytosolic
proteins, Noxo1 and Noxa1, to the cell membrane, where
Nox1 is embedded. In unstimulated A431 cells expressing
GFP-tagged Noxo1, GFP was visualized in the cytosol, and
phosphorylated PrxI was not detected. Upon stimulation of the
cells with EGF, both GFP and phosphorylated PrxI appeared in
the membrane, and the signals for the two proteins colocalized
perfectly (Figure S4B).
Phosphorylation of PrxI during Cutaneous Wound
Healing
During the process of wound healing, epidermal cells, endothe-
lial cells, and infiltrated immune cells release various growth
factors that initiate re-epithelializaton by inducing the migration522 Cell 140, 517–528, February 19, 2010 ª2010 Elsevier Inc.and proliferation of keratinocytes, fibroblasts, and endothelial
cells (Martin, 1997; Singer and Clark, 1999). We therefore inves-
tigated whether phosphorylation of PrxI on Tyr194 might occur
during cutaneous wound repair. The back skin of Balb/c mice
was subjected to an incisional injury, and skin tissue was
collected at various stages of healing for preparation of protein
extracts (Figure S5A). The amount of phosphorylated PrxI
increased markedly during the early stage of wound healing,
even though the total amount of PrxI decreased in the tissue
surrounding the wound area (Figure S5A). We next separated
the wound region into the wound edge and the surrounding
regenerated area (Figure 5A). Phosphorylation of PrxI was
pronounced in the tissue from the wound edge, where growth
factors actively promote re-epithelialization, but it was not
readily apparent in the tissue from the regenerated area (Fig-
ure 5A). The phosphorylation of PrxI at the wound edge was
Figure 5. Phosphorylation of PrxI at the Wound Margin during Cutaneous Wound Repair
(A) Balb/c mice were subjected to a full-thickness excisional injury on the back skin, and full-thickness tissue was collected from the areas corresponding to the
wound edge (red circle) and the surrounding regenerated region (region between the red and blue circles) at the indicated times thereafter. Protein extracts
prepared from the tissue were then subjected to immunoblot analysis with antibodies to phosphorylated or total PrxI.
(B) Protein extracts prepared from the repaired area at 2 days after excisional injury of wild-type or Nox2 knockout mice were subjected to immunoblot analysis as
in (A) (upper panel). The relative extent of PrxI phosphorylation was estimated from the band intensities in immunoblots similar to that shown (lower panel); data
shown as are mean ± SEM from five independent measurements.
See also Figure S5.prominent between 1 and 7 days after wounding despite a
concomitant marked decrease in the total amount of PrxI. The
amount of PrxII in the wound area was also decreased during
this same period, whereas that of GPx1 was increased (Fig-
ure S5B). The apparent decline in the abundance of both PrxI
and PrxII might be due to the introduction of a large amount of
proteins such as fibrin from clots at the wound site. The apparent
increase in the amount of GPx1 after injury is likely attributable to
its high level of expression in infiltrated immune cells compared
with that in skin (Figure S5B).
In addition to activating PTKs, growth factors increase H2O2
production by various Nox enzymes present in target cells
(Lambeth, 2004). Phagocytic cells recruited to the wound site
also produce H2O2 to kill contaminating bacteria. The increased
level of H2O2 in the wound fluid, which can achieve micromolar
concentrations during the inflammatory phase, facilitates the
healing process through redox-sensitive signaling pathways(Sen and Roy, 2008). We therefore examined whether PrxI phos-
phorylation in the epidermis during wound repair depended on
H2O2 produced by recruited phagocytic cells. Nox2 is a key
source of H2O2 in phagocytic cells, and we found that the extent
of PrxI phosphorylation in tissue from the wound edge was
similar in wild-type and Nox2 knockout mice (Figure 5B), sug-
gesting that H2O2 produced by phagocytic cells does not
contribute to the observed phosphorylation of PrxI.
Relative Sensitivity of PrxI and PrxII to Hyperoxidation
The peroxidase activity of PrxII in vitro is only 30% of that of PrxI
(Chae et al., 1999) (Figure 6A) and is more rapidly extinguished
during catalysis as a result of a greater susceptibility of the
CP-SH to hyperoxidation (Figure 6A). We examined the hyperox-
idation of PrxI and PrxII in HeLa cells exposed to glucose oxidase
in the presence of glucose in order to maintain a steady flux of
low levels of H2O2. Hyperoxidation, like phosphorylation, resultsCell 140, 517–528, February 19, 2010 ª2010 Elsevier Inc. 523
Figure 6. Differential Sensitivity of PrxI and PrxII to Inactivation by Hyperoxidation
(A) The peroxidase activity of 5 mg PrxI (open circles) or 15 mg PrxII (closed triangle) was monitored at 30C as a decrease in A340 by coupling of the reaction to
NADPH oxidation in an assay mixture (200 ml) containing 50 mM HEPES-NaOH (pH 7.0), 1 mM EDTA, 300 mM NADPH, 50 nM Trx reductase, 10 mg Trx, and 50 mM
H2O2. NADPH oxidation in the absence of any Prx enzyme (closed circles) was also monitored.
(B) HeLa cells were incubated for the indicated times with glucose oxidase (30 mU/ml). Cell lysates (250 mg protein) were then analyzed by 2D-PAGE followed by
immunoblot analysis with antibodies to PrxI or to PrxII as well as with antibodies specific for hyperoxidized 2-Cys Prxs (Prx–SO2). Ox and Re indicate oxidized and
reduced forms, respectively, of PrxI or II.
(C) Lysates of NIH 3T3 cells that had been exposed to 20 mM paraquat for 8 hr were subjected to 2D-PAGE followed by immunoblot analysis as in (B).
(D) Serum-deprived NIH 3T3 cells were incubated for 15 min in the absence (Con.) or presence of PDGF (25 ng/ml) and 20 mM H2O2, after which cell lysates (250 mg
protein) were subjected to 2D-PAGE followed by immunoblot analysis as in (B) as well as with antibodies to phosphorylated PrxI. The positions of phosphorylated
and nonphosphorylatd PrxI as well as those of oxidized (Ox) and reduced (Re) PrxII are indicated. Tyr194-phosphorylated PrxI is detected at two spots, probably
because PrxI undergoes an additional unknown modification when stimulated with PDGF plus H2O2.
See also Figure S6.in an acidic shift of PrxI or II on 2D-PAGE. Exposure of the cells to
the generated H2O2 for 0.5 or 1.5 hr resulted in the hyperoxida-
tion of 30% and 60% of PrxII, respectively, whereas the cor-
responding values for PrxI were only 5% and 10% (Fig-
ure 6B). Preferential hyperoxidation of PrxII was also observed
in NIH 3T3 cells treated with paraquat (an H2O2 generator):
whereas 50% of PrxII was hyperoxidized, PrxI hyperoxidation
was not detected (Figure 6C). We then examined the relative
sensitivities of PrxI and PrxII to tyrosine phosphorylation and
hyperoxidation simultaneously by exposing NIH 3T3 cells to
both PDGF and 20 mM H2O2 (Figure 6D). PrxI, but not PrxII,
was found to undergo phosphorylation, whereas only PrxII
underwent hyperoxidation.
This differential susceptibility of PrxI and PrxII to phosphoryla-
tion and hyperoxidation suggested that these enzymes might
play distinct roles in cell signaling. Hyperoxidation of 2-Cys524 Cell 140, 517–528, February 19, 2010 ª2010 Elsevier Inc.Prxs results in a structural transition from a dimer to a toroid dec-
amer that can undergo further aggregation, and the decameric
and aggregated forms of the enzymes gain protein chaperone
function (Jang et al., 2006). Phosphorylation of PrxI on Thr90 by
a cyclin B-dependent kinase also promotes oligomerization to
a decamer (Jang et al., 2006). We therefore determined whether
phosphorylation of PrxI on Tyr194 might also induce oligomeriza-
tion. Gel filtration chromatography revealed that phosphorylated
PrxI molecules from NIH 3T3 cells stimulated with PDGF existed
as dimers, whereas all hyperoxidized PrxI and PrxII in cells
exposed to 1 mM H2O2 were found in the positions correspond-
ing to decamers (PrxI is also hyperoxidized when cells are
exposed to H2O2 at 1 mM) (Figure S6). Thus, unlike hyperoxida-
tion and threonine phosphorylation, tyrosine phosphorylation
of PrxI does not induce the structural changes that confer
chaperone function.
DISCUSSION
Mammalian cells produce H2O2 for the purpose of intracellular
signaling when stimulated through various cell surface recep-
tors. H2O2 is distinct from other messenger molecules in that it
acts not by binding to effectors but by oxidizing their critical resi-
dues, most notably cysteine, as exemplified by inhibition of PTPs
and the tumor suppressor PTEN as a result of oxidation of their
catalytic cysteine by H2O2 produced in response to stimulation
of cells with growth factors (Rhee et al., 2005; Tonks, 2005). It
has remained unclear, however, how a toxic molecule like
H2O2 is able to oxidize effector proteins selectively without
inflicting damage on other proteins and lipids. This question
has been addressed in part recently by the finding that Nox-
dependent production of H2O2 molecules for intracellular sig-
naling is localized (Oakley et al., 2009; Ushio-Fukai, 2006).
We have now shown that PrxI becomes phosphorylated on
Tyr194 in several cell types stimulated via various receptors,
including PDGFR, EGFR, BCR, and TCR. Kinetic analysis
revealed that phosphorylation of PrxI on Tyr194 conferred a
long lag time before the onset of peroxidase activity at a reduced
level compared with that of the nonphosphorylated enzyme. The
lag time was found to be inversely related to the concentration of
H2O2, suggesting that phosphorylated PrxI would remain inac-
tive as long as H2O2 levels around confined membrane microdo-
mains are low. These results indicate that localized production of
H2O2 might not be sufficient to support the messenger function
of this molecule in cells stimulated via growth factor or immune
receptors, with inactivation of PrxI by phosphorylation on
Tyr194 being necessary to protect the pool of H2O2 signaling
molecules from destruction by this abundant and catalytically
efficient enzyme. The absolute amount of Tyr194-phosphorylated
PrxI was found to be low because the phosphorylation reaction
is confined to PrxI molecules associated with membranes. This
selective phosphorylation allows the bulk of PrxI to remain
engaged in elimination of H2O2 molecules, including those that
escape from the site of receptor signaling. Our observation
that PrxI phosphorylation was facilitated by Nox1 activation is
consistent with the notion that PrxI phosphorylation occurs in
the cellular microdomains where H2O2 is produced.
The phosphorylation of PrxI on Tyr194 was also observed at the
wound edge during repair of a cutaneous injury in mice. This
finding is likely due to the fact that growth factors such as
EGF, PDGF, fibroblast growth factors, transforming growth
factor-a, keratinocyte growth factor, and insulin-like growth
factor-1 act as key inducers of the proliferation of keratinocytes
and fibroblasts at the wound edge (Singer and Clark, 1999). The
H2O2 produced by infiltrating phagocytic cells is thought to have
a beneficial effect on healing by stimulating angiogenesis as well
as inducing the tyrosine phosphorylation of focal adhesion
kinase (Sen and Roy, 2008). However, the extent of PrxI phos-
phorylation at the wound edge was not affected by the ablation
of Nox2, suggesting that the amount of H2O2 released by phago-
cytic cells at the wound site was not sufficient to increase PrxI
phosphorylation. PDGF-induced PrxI phosphorylation was,
however, markedly increased by potentiation of H2O2 accumula-
tion in HepG2 cells by forced expression of Nox1 and the auxil-
iary proteins Noxo1 and Noxa1. The role of Nox1-derived H2O2 inPrxI phosphorylation was demonstrated again by the observa-
tion that the extent of EGF- and PDGF-induced PrxI phosphory-
lation in primary keratinocytes prepared from mice deficient in
Nox1 was reduced by up to 60% compared with that apparent
in wild-type cells. Our results with HepG2 cells and keratinocytes
thus suggest that H2O2 generated by growth factor-activated
Nox1 induces inactivation of PrxI by inactivating PTPs, which
in turn promotes the further accumulation of H2O2.
A model illustrating the mechanism underlying H2O2 accumu-
lation around a submembrane compartment and its role in intra-
cellular signaling is shown in Figure 7. Engagement of a growth
factor receptor induces the production of H2O2 by activating
Nox associated with membranes. At the same time, the acti-
vated receptor induces the phosphorylation of cell membrane-
associated PrxI on Tyr194 by activating a Src family PTK, result-
ing in inactivation of PrxI, which would otherwise destroy the
newly generated H2O2. Inactivation of PrxI allows the accumula-
tion of H2O2 around a submembrane compartment, which in turn
promotes further phosphorylation and inactivation of PrxI both
by activating Src kinases and by inactivating PTPs. These two
positive feedback loops allow the sustained H2O2 signaling
necessary for the regulation of biological responses. H2O2 is
known to activate Src directly by oxidizing its Cys residues or
indirectly by inhibiting PTPs (Chiarugi, 2008). The inhibition of
PTPs by H2O2 is critical for growth factor signaling because acti-
vation of receptor PTKs alone is not sufficient to achieve the
levels of protein tyrosine phosphorylation necessary for such
signaling, with the concurrent inhibition of PTPs by H2O2 pre-
venting the futile cycle of phosphorylation and dephosphoryla-
tion. Reversible inactivation of PTEN by H2O2 is also necessary
for signaling mediated by phosphoinositide 3-kinase (Rhee
et al., 2005). A similar scenario likely applies to H2O2 signaling
in cells stimulated via BCR or TCR.
The predisposition of eukaryotic Prxs to hyperoxidation has
been proposed to provide a ‘‘floodgate’’ that permits H2O2 to
accumulate in order to perform its signaling functions (Wood
et al., 2003). However, PDGF-induced hyperoxidation of PrxI
or II was not observed even when heightened downstream sig-
naling effects of H2O2 were apparent, indicating that H2O2
produced at cell membranes by Nox does not hyperoxidize
PrxI or II and that growth factor signaling does not require inac-
tivation of the two membrane-bound Prxs via hyperoxidation.
This finding is consistent with previous observations that normal
mitogenic signaling does not require inactivation of 2-Cys Prxs
by hyperoxidation (Choi et al., 2005; Phalen et al., 2006). Rather,
we found that hyperoxidation of PrxI or II appears to occur as the
result of a global increase in the intracellular concentration of
H2O2, which is consistent with the observation that sulfiredoxin
is induced only when cells are exposed to severe oxidative stress
(Bae et al., 2009).
Our results show that PrxI and PrxII are regulated differently:
PrxI is selectively phosphorylated by PTKs and functions as
a modulator of local H2O2 levels, whereas PrxII is more suscep-
tible to hyperoxidation in cells subjected to sustained global
oxidative stress. Although both PrxI and PrxII are associated
with detergent-resistant membranes, inactivation of PrxI, which
is more efficient as a peroxidase than PrxII, might be sufficient to
allow local accumulation of H2O2 for signal propagation. The roleCell 140, 517–528, February 19, 2010 ª2010 Elsevier Inc. 525
Figure 7. A Model Illustrating the Mechanism Underlying H2O2 Accumulation around a Submembrane Compartment and Its Role in Intracel-
lular Signaling
See the Discussion for details. GF, growth factor.of membrane-associated PrxII remains unclear. Given that the
accumulation of a small amount of H2O2 at membranes can
trigger rapid signal amplification through the action of positive
feedback loops (Figure 7), the presence of PrxII in addition to
PrxI might function as a safeguard to prevent inappropriate acti-
vation of signaling cascades by basal production of H2O2 at cell
membranes. Consistent with this notion, cells derived from PrxII-
deficient mice exhibit enhanced tyrosine phosphorylation of
PDGFR when stimulated with PDGF (Choi et al., 2005). Func-
tional differences between PrxI and PrxII are also apparent in
the phenotypes of the corresponding knockout mice: mice lack-
ing PrxI thus manifest an increased susceptibility to cancer,
whereas those deficient in PrxII do not (Neumann et al., 2003).
PrxI has thus been suggested to play a tumor suppressor role,
and this suggestion was further supported by the observation
that PrxI deficiency in mice increases the susceptibility to Ras-
or ErbB-2-induced breast cancer (Cao et al., 2009). Tumor
suppression by PrxI was attributed to its ability to bind to
PTEN and to protect its lipid phosphatase activity from oxidative
inactivation by removing H2O2 produced in response to pro-
liferative signals (Cao et al., 2009). PrxII did not bind PTEN
(Cao et al., 2009). Given that PrxI activity is critical for maintaining526 Cell 140, 517–528, February 19, 2010 ª2010 Elsevier Inc.the activation of PTPs and likely PTEN also in the vicinity of the
same microdomain, tumor suppression by PrxI is also likely




Rabbit antisera specific for PrxI, PrxII, or hyperoxidized 2-Cys Prxs were
described previously (Kang et al., 1998; Woo et al., 2003b). Antibodies to
EGFR phosphorylated on Tyr1068, to Tyr416-phosphorylated or total forms of
Src, or to Flot2 were obtained from Cell Signaling; antibodies to GPx1 were
from Young In Frontier; antibodies to human IgM were from Jackson Labora-
tory; antibodies to phosphotyrosine (4G10), agarose-conjugated 4G10, and
recombinant human EGF were from Upstate Biotechnology; antibodies to
CD3 was from BD Bioscience; purified recombinant Lck and Abl as well as
AG1478 were from Calbiochem; PP1 was from Biomol Research Laboratories;
paraquat and glucose oxidase was from Sigma; rat PDGF-BB was from R&D
Systems; and STI571 (imatinib mesylate) was from Novartis.
Antibodies to PrxI Phosphorylated on Tyr194
Rabbits were injected with keyhole limpet hemocyanin (Pierce) conjugated
to the phosphopeptide KSKEpYFSKQK, which corresponds to residues
190 to 199 of mammalian PrxI. To remove antibodies that recognize the
corresponding nonphosphorylated peptide, we applied serum subsequently
obtained from the rabbits to Sepharose 4B resin (GE Healthcare) conjugated
with the nonphosphorylated peptide. The unbound fraction was used for
immunoblot and immunofluorescence analyses of phosphorylated PrxI or II.
Expression and Purification of PrxI and PrxII
The construction of bacterial expression plasmids for human PrxI and II was
described previously (Kang et al., 1998). Mutation of Tyr194 of PrxI to aspartate
(Y194D) or to phenylalanine (Y194F) was performed with the use of a site-
directed mutagenesis kit (Stratagene). Plasmids encoding wild-type PrxI,
mutant PrxI, or wild-type PrxII were introduced into E. coli BL21(DE3) cells,
and the encoded proteins were purified from bacterial extracts as described
(Kang et al., 1998).
Cell Culture
A431 cells, HeLa cells, MEFs, as well as HepG2 cells stably expressing PDGFR
and Nox1 were maintained under 5% CO2 at 37
C in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum (FBS),
penicillin (100 U/ml), and streptomycin (100 U/ml). NIH 3T3 cells and HER cells
(Prywes et al., 1986) were maintained in DMEM supplemented with 10% calf
serum, penicillin, and streptomycin. Smooth muscle cells were isolated by
enzymatic digestion of the aorta from Sprague-Dawley rats, maintained in
DMEM supplemented with 10% FBS, penicillin, and streptomycin, and used
for experiments in passages three to five. Keratinocytes were isolated from
newborn homozygous Nox1 knockout mice (Matsuno et al., 2005) and genet-
ically matched wild-type controls as described (Lichti et al., 2008); they were
cultured in minimal essential medium supplemented with 10% FBS. PrxI
knockout mice will be described elsewhere. Ramos cells and Jurkat cells
were maintained in RPMI supplemented with 10% FBS, penicillin, and strep-
tomycin.
Isolation of Detergent-Soluble and -Resistant Fractions
A431, NIH 3T3, Ramos, or Jurkat cells were subjected to the procedure of
Radeva and Sharom (Radeva and Sharom, 2004) with a slight modification.
In brief, stimulated cells (23 108 cells) were suspended in 1 ml lysis buffer con-
taining of 0.5% Brij-96 in 25 mM Tris-HCl, 140 mM NaCl, 1 mM EDTA, 1 mM
AEBSF, and 1 mM Na3VO4. Cells were left on ice for 30 min to lyse and
were then centrifuged at 10,000 3 g for 5 min to obtain the postnuclear frac-
tion. The postnuclear lysate was adjusted to 40% (w/v) sucrose in the same
buffer, and then a 5%–30% discontinuous sucrose gradient was layered on
the top. Samples were centrifuged at 36,000 rpm for 20 hr at 4C with
a SW41 rotor (Beckman Coulter). Fractions of 0.8 ml were collected from the
top of the gradient tube.
Mouse Model of Cutaneous Wound Repair
Balb/c mice or homozygous Nox2 knockout mice (Jackson Laboratory) and
their corresponding wild-type controls (all at 10 to 12 weeks of age) were
used for the wounding experiments. All animal experiments were performed
according to a protocol approved by the Institutional Animal Care and Use
Committee of Ewha Womans University. Mice were anesthetized by intraper-
itoneal injection of a mixture of tiletamine, zolazepam, and xylazine, and two
full-thickness excisional wounds were made on the back skin of the animals
with the use of a 6 mm biopsy punch. Wound tissue was collected at various
times after wounding, frozen in liquid nitrogen, and subsequently used to
prepare protein extracts.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
six figures and can be found with this article online at doi:10.1016/j.cell.
2010.01.009.
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